Central Pacific Bank Trust Division Purchases 415 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Central Pacific Bank Trust Division raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,348 shares of the company’s stock after acquiring an additional 415 shares during the quarter. Central Pacific Bank Trust Division’s holdings in GE HealthCare Technologies were worth $502,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Pathway Financial Advisers LLC bought a new stake in GE HealthCare Technologies during the first quarter valued at $25,000. Fred Alger Management LLC bought a new stake in GE HealthCare Technologies during the second quarter valued at $26,000. BNP Paribas bought a new position in shares of GE HealthCare Technologies during the 1st quarter worth about $30,000. Rise Advisors LLC boosted its position in shares of GE HealthCare Technologies by 241.4% during the 1st quarter. Rise Advisors LLC now owns 338 shares of the company’s stock worth $31,000 after purchasing an additional 239 shares in the last quarter. Finally, Riverview Trust Co bought a new position in shares of GE HealthCare Technologies during the 1st quarter worth about $31,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.3 %

NASDAQ:GEHC opened at $89.88 on Friday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The firm has a market cap of $41.03 billion, a price-to-earnings ratio of 26.28, a price-to-earnings-growth ratio of 3.40 and a beta of 1.17. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.55. The firm has a 50-day moving average price of $85.83 and a two-hundred day moving average price of $83.33.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. The firm had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter last year, the business posted $0.92 EPS. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares in the company, valued at approximately $1,414,377.02. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.27% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on GEHC shares. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. JPMorgan Chase & Co. started coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective on the stock. Finally, BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research report on Wednesday, September 18th. One analyst has rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.23.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.